Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Velo-cardio-facial Syndrome, Psychosis

In brief

This is an exploratory clinical investigation. The objectives of this study are to evaluate the safety, steady-state pharmacokinetics, and efficacy of metyrosine (Demser®) for the treatment of psychosis in patients with velocardiofacial syndrome (VCFS).

Key facts

Study ID

NCT01127503

Run by

Bausch Health Americas, Inc.

People needed

2

Starts

2010-06-01

Expected to finish

2011-09-01

Last updated by the study team

2019-11-22

Who can join

Age: 16 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• VCFS International Center — Syracuse, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.